ASTRAZEN.BO
Price:
$9211.5
Market Cap:
$230.66B
AstraZeneca Pharma India Limited, a biopharmaceutical company, engages in manufacturing, distributing, and marketing of pharmaceutical products in India and internationally. It manufactures and sells cardiovascular disease and diabetes medicines under the Brilinta, Betaloc, Crestor, Forxiga, Imdur, Kombiglyze XR, Onglyza, Seloken XL, Xigduo XR, and QTERN brand names; Respiratory medicines under the Symbicort and FASENRA brand names; and oncology medicines under the LYNPARZA, Tagrisso, Iressa, Calquence, Casodex, Faslodex, Zoladex, and Arimidex brand names. The company also offers products in the areas of renal, metabolic, and immunology diseases. It also provides clinical trial services. The...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2000-07-10
Stock Exchange
BSE
Ticker
ASTRAZEN.BO
According to AstraZeneca Pharma India Limited’s latest financial reports and current stock price. The company's current ROE is 26.39%. This represents a change of 303.82% compared to the average of 6.53% of the last 4 quarters.
The mean historical ROE of AstraZeneca Pharma India Limited over the last ten years is 14.79%. The current 26.39% ROE has changed 78.46% with respect to the historical average. Over the past ten years (40 quarters), ASTRAZEN.BO's ROE was at its highest in in the September 2017 quarter at 12.68%. The ROE was at its lowest in in the December 2017 quarter at -4.79%.
Average
14.79%
Median
15.95%
Minimum
3.37%
Maximum
22.69%
Discovering the peaks and valleys of AstraZeneca Pharma India Limited ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 166.89%
Maximum Annual ROE = 22.69%
Minimum Annual Increase = -124.38%
Minimum Annual ROE = 3.37%
| Year | ROE | Change |
|---|---|---|
| 2025 | 15.02% | -33.77% |
| 2024 | 22.69% | 34.51% |
| 2023 | 16.87% | 40.02% |
| 2022 | 12.05% | -41.11% |
| 2021 | 20.45% | 3.22% |
| 2020 | 19.81% | 9.46% |
| 2019 | 18.10% | 72.51% |
| 2018 | 10.49% | 16.64% |
| 2017 | 9.00% | 166.89% |
| 2016 | 3.37% | -124.38% |
The current ROE of AstraZeneca Pharma India Limited (ASTRAZEN.BO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
18.19%
5-year avg
17.42%
10-year avg
14.79%
AstraZeneca Pharma India Limited’s ROE is less than Neuland Laboratories Limited (15.84%), less than Neuland Laboratories Limited (15.84%), less than Piramal Enterprises Limited (2.15%), greater than Piramal Pharma Limited (-0.29%), less than J. B. Chemicals & Pharmaceuticals Limited (20.70%), less than J. B. Chemicals & Pharmaceuticals Limited (20.70%), less than Eris Lifesciences Limited (13.41%), less than Eris Lifesciences Limited (13.41%), greater than Wockhardt Limited (-0.53%), greater than Wockhardt Limited (-0.53%),
| Company | ROE | Market cap |
|---|---|---|
| 15.84% | $216.66B | |
| 15.84% | $216.87B | |
| 2.15% | $254.86B | |
| -0.29% | $238.09B | |
| 20.70% | $285.95B | |
| 20.70% | $285.72B | |
| 13.41% | $211.37B | |
| 13.41% | $211.51B | |
| -0.53% | $220.99B | |
| -0.53% | $221.01B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like AstraZeneca Pharma India Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like AstraZeneca Pharma India Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is AstraZeneca Pharma India Limited's ROE?
How is the ROE calculated for AstraZeneca Pharma India Limited (ASTRAZEN.BO)?
What is the highest ROE for AstraZeneca Pharma India Limited (ASTRAZEN.BO)?
What is the 3-year average ROE for AstraZeneca Pharma India Limited (ASTRAZEN.BO)?
What is the 5-year average ROE for AstraZeneca Pharma India Limited (ASTRAZEN.BO)?
How does the current ROE for AstraZeneca Pharma India Limited (ASTRAZEN.BO) compare to its historical average?